About Epoch Biodesign
Epoch Biodesign is a company based in London (United Kingdom) founded in 2019 by Jacob Nathan. Epoch Biodesign has raised $41.3 million across 4 funding rounds from investors including Gov.uk, Inditex and Lowercarbon. The company has 25 employees as of March 31, 2024. Epoch Biodesign offers products and services including Biorecycling Platform and AI-Designed Enzymes.
- Headquarter London, United Kingdom
- Employees 25 as on 31 Mar, 2024
- Founders Jacob Nathan
-
Sectors
Transportation, Automotive & Logistics
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Epoch Biodesign Ltd
- Date of Incorporation 13 Feb, 2019
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$41.3 M (USD)
in 4 rounds
-
Latest Funding Round
$12 M (USD), Series A
Mar 24, 2026
-
Investors
Gov.uk
& 17 more
-
Employee Count
25
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epoch Biodesign
Epoch Biodesign offers a comprehensive portfolio of products and services, including Biorecycling Platform and AI-Designed Enzymes.
AI-driven platform for infinite recycling of plastics and textiles.
Enzymes that enable low-temperature recycling for mixed materials.
People of Epoch Biodesign
Unlock access to complete
Funding Insights of Epoch Biodesign
Epoch Biodesign has successfully raised a total of $41.3M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $12 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Epoch Biodesign
Epoch Biodesign has secured backing from 18 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, Inditex and Lowercarbon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Extantia is focused on investing in climate technology pioneers.
|
Locked | Locked | Locked | |
|
Early-stage investments are targeted globally by this VC fund.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Epoch Biodesign
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Epoch Biodesign
Investment portfolio details for Epoch Biodesign
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Epoch Biodesign
Detailed financials for Epoch Biodesign
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epoch Biodesign Comparisons
Peer comparison for Epoch Biodesign
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Epoch Biodesign
Detailed competitors of Epoch Biodesign
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epoch Biodesign
Complete news archive for Epoch Biodesign
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epoch Biodesign
Epoch Biodesign was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Epoch Biodesign is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Jacob Nathan is the current CEO of Epoch Biodesign. They have also founded this company.
Epoch Biodesign is a funded company, having raised a total of $41.3M across 4 funding rounds to date.
As of Mar 31, 2024, the latest employee count at Epoch Biodesign is 25.
Epoch Biodesign was founded in 2019 in London, United Kingdom. A biorecycling platform is operated by the company within the sustainability and materials science sector. Mixed plastics and textiles, including nylon and polyester, are processed using AI-designed enzymes for low-temperature recycling. Outputs are generated for applications in apparel, automotive, and packaging industries. Synthetic biology, process engineering, and AI are integrated to manage waste streams effectively.
Epoch Biodesign offers Biorecycling Platform and AI-Designed Enzymes.
Epoch Biodesign has 18 investors. Key investors include Gov.uk, Inditex, Lowercarbon, Voyagers, and Extantia.